New Delhi: Days after doctors at a leading private facility in Delhi witnessed a rise in the number of COVID-triggered mucormycisis cases, a number of COVID patients, including those recovering from the disease, at an Ahmedabad hospital have been diagnosed with a fungal infection.
The mucormycosis, or black fungus, which can be fatal for transplant recipients, people in ICU or those who have long-term immunodeficiency concerns.
Dr Kalpesh Patel, an Associate Professor at the BJ Medical College and Civil Hospital, told news agency ANI 67 such patients, from the ENT ward, had been identified in the past 20 days alone.
“Of these 45 have yet to undergo surgery. We’re doing five to seven operations daily,” he said.
News of black fungal infections from Ahmedabad comes days after doctors at a leading Delhi hospital told news agency PTI “we are seeing a rise again in this dangerous fungal infection”.
“In the last two days, we have admitted six cases of mucormycosis. Last year this infection caused high mortality with many suffering from loss of eyesight and removal of nose and jaw bone,” Dr Manish Munjal, a senior ENT surgeon at Delhi’s Sir Ganga Ram Hospital, said on Thursday.
Dr Ajay Swaroop, Chairman of the hospital’s ENT department, told NDTV that the use of steroids in treating COVID-19 patients, coupled with the fact that many coronavirus patients have diabetes, could be one reason for the increase in the number of black fungus cases.